The European Commission has approved Rytelo treatment in transfusion-dependent anemia due to very low–, low– or ...

Guard Therapeutics announced today that it has reached another key milestone in its ongoing clinical development program. Two-thirds of the approximately 160 planned patients have now been enrolled in ...